Non-communicable diseases in sub-Saharan Africa: a scoping review of large cohort studies.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
Dec 2019
Historique:
entrez: 27 8 2019
pubmed: 27 8 2019
medline: 3 9 2019
Statut: ppublish

Résumé

Non-communicable diseases (NCDs) cause a large and growing burden of morbidity and mortality in sub-Saharan Africa. Prospective cohort studies are key to study multiple risk factors and chronic diseases and are crucial to our understanding of the burden, aetiology and prognosis of NCDs in SSA. We aimed to identify the level of research output on NCDs and their risk factors collected by cohorts in SSA. We conducted a scoping review to map the extent of current NCDs research in SSA by identifying studies published after the year 2000 using prospectively collected cohort data on any of the six NCDs (cardiovascular diseases, diabetes, obesity, chronic kidney disease, chronic respiratory diseases, and cancers), ≥1 major risk factor (other than age and sex), set only within SSA, enrolled ≥500 participants, and ≥12 months of follow-up with ≥2 data collection points (or with plans to). We performed a systematic search of databases, a manual search of references lists from included articles and the INDEPTH network website, and study investigators from SSA were contacted for further articles. We identified 30 cohort studies from the 101 included articles. Eighteen countries distributed in West, Central, East and Southern Africa, were represented. The majority (27%) set in South Africa. There were three studies including children, twenty with adults, and seven with both. 53% of cohorts were sampled in general populations, 47% in clinical populations, and 1 occupational cohort study. Hypertension (n = 23) was most commonly reported, followed by obesity (n = 16), diabetes (n = 15), CKD (n = 6), COPD (n = 2), cervical cancer (n = 3), and breast cancer (n = 1). The majority (n = 22) reported data on at least one demographic/environmental, lifestyle, or physiological risk factor but these data varied greatly. Most studies collected data on a combination of hypertension, diabetes, and obesity and few studies collected data on respiratory diseases and cancer. Although most collected data on different risk factors the methodologies varied greatly. Several methodological limitations were found including low recruitment rate, low retention rate, and lack of validated and standardized data collection. Our results could guide potential collaborations and maximize impact to improve our global understanding of NCDs (and their risk factors) in SSA and also to inform future research, as well as policies.

Sections du résumé

BACKGROUND BACKGROUND
Non-communicable diseases (NCDs) cause a large and growing burden of morbidity and mortality in sub-Saharan Africa. Prospective cohort studies are key to study multiple risk factors and chronic diseases and are crucial to our understanding of the burden, aetiology and prognosis of NCDs in SSA. We aimed to identify the level of research output on NCDs and their risk factors collected by cohorts in SSA.
METHODS METHODS
We conducted a scoping review to map the extent of current NCDs research in SSA by identifying studies published after the year 2000 using prospectively collected cohort data on any of the six NCDs (cardiovascular diseases, diabetes, obesity, chronic kidney disease, chronic respiratory diseases, and cancers), ≥1 major risk factor (other than age and sex), set only within SSA, enrolled ≥500 participants, and ≥12 months of follow-up with ≥2 data collection points (or with plans to). We performed a systematic search of databases, a manual search of references lists from included articles and the INDEPTH network website, and study investigators from SSA were contacted for further articles.
RESULTS RESULTS
We identified 30 cohort studies from the 101 included articles. Eighteen countries distributed in West, Central, East and Southern Africa, were represented. The majority (27%) set in South Africa. There were three studies including children, twenty with adults, and seven with both. 53% of cohorts were sampled in general populations, 47% in clinical populations, and 1 occupational cohort study. Hypertension (n = 23) was most commonly reported, followed by obesity (n = 16), diabetes (n = 15), CKD (n = 6), COPD (n = 2), cervical cancer (n = 3), and breast cancer (n = 1). The majority (n = 22) reported data on at least one demographic/environmental, lifestyle, or physiological risk factor but these data varied greatly.
CONCLUSIONS CONCLUSIONS
Most studies collected data on a combination of hypertension, diabetes, and obesity and few studies collected data on respiratory diseases and cancer. Although most collected data on different risk factors the methodologies varied greatly. Several methodological limitations were found including low recruitment rate, low retention rate, and lack of validated and standardized data collection. Our results could guide potential collaborations and maximize impact to improve our global understanding of NCDs (and their risk factors) in SSA and also to inform future research, as well as policies.

Identifiants

pubmed: 31448113
doi: 10.7189/jogh.09.020409
pii: jogh-09-020409
pmc: PMC6684871
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

020409

Subventions

Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

Competing interests: PP holds a grant and KM reports a grant from GlaxoSmithKline (GSK). JA, LK, and AA are full-time employees of GSK and are shareholders at GSK. KM spent two months on secondment as a complimentary worker at the GSK Africa NCD Open Laboratory in order to interact with GSK experts for their input into the study. The design of the study and the writing of the report was a joint collaborative effort with the funder. The authors completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available upon request from the corresponding author), and declare no further conflicts of interest.

Références

PLoS Med. 2010 May 11;7(5):e1000244
pubmed: 20485489
Cardiovasc J Afr. 2012 Mar;23(2):103-12
pubmed: 21901226
J Glob Health. 2011 Jun;1(1):46-58
pubmed: 23198102
Bull World Health Organ. 2013 Sep 1;91(9):683-90
pubmed: 24101784
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S8-16
pubmed: 25117964
Lancet Glob Health. 2015 Jan;3(1):e6-7
pubmed: 25539971
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Int Health. 2016 May;8(3):157-8
pubmed: 27178673
PLoS One. 2017 Apr 20;12(4):e0174767
pubmed: 28426819
Health Res Policy Syst. 2017 Jul 12;15(Suppl 1):55
pubmed: 28722555
BMC Public Health. 2018 May 25;18(1):660
pubmed: 29801446

Auteurs

Kathleen Mudie (K)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Melisa Mei Jin (MM)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Biostatistics, GlaxoSmithKline, Stevenage, UK.
Africa NCD Open Lab, Global Health Catalyst, GlaxoSmithKline, Stevenage, UK.
Population and Occupational Disease, National Heart and Lung Institute, Imperial College London, London, UK.
MRC/UVRI and LSHTM Uganda Research Unit.
MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, University of the Witwatersrand, South Africa.
Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

Lindsay Kendall (L)

Biostatistics, GlaxoSmithKline, Stevenage, UK.

Juliet Addo (J)

Africa NCD Open Lab, Global Health Catalyst, GlaxoSmithKline, Stevenage, UK.

Isabel Dos-Santos-Silva (I)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Jennifer Quint (J)

Population and Occupational Disease, National Heart and Lung Institute, Imperial College London, London, UK.

Liam Smeeth (L)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Sarah Cook (S)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Dorothea Nitsch (D)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Barnabas Natamba (B)

MRC/UVRI and LSHTM Uganda Research Unit.

Francesc Xavier Gomez-Olive (FX)

MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, University of the Witwatersrand, South Africa.

Agbor Ako (A)

Africa NCD Open Lab, Global Health Catalyst, GlaxoSmithKline, Stevenage, UK.

Pablo Perel (P)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH